Volpara Health Surpasses 300 Peer-Reviewed Papers
Milestone reinforces readership in AI-powered breast cancer detection WELLINGTON, New Zealand, Oct. 24, 2024 /PRNewswire/ -- Volpara Health, a Lunit company...
Cancer
Healthcare Analytics Market is expected to generate a revenue of USD 18.05 Billion by 2031, Globally, at 2.50% CAGR: Verified Market Research®
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its...
deepc and The AI Centre for Value-Based Healthcare enter partnership to accelerate and transform NHS adoption of radiology AI
Long-term strategic collaboration will support The AI Centre for Value-Based Healthcare's mission and enable faster, more effective adoption of clinically...
AAD awarded BARDA contract to develop next gen CBC, sepsis diagnostic system
System targets faster, earlier, easier CBC results and severe infection detection MORRISVILLE, N.C., Oct. 24, 2024 /PRNewswire/ -- Ad Astra Diagnostics (AAD),...
Nest Genomics Joins athenahealth’s Marketplace Program to Bring the Power of Genomics to the Point of Care
Integrating genomics into clinical workflows and empowering patients and providers with actionable genetic information NEW YORK, Oct. 24, 2024 /PRNewswire/...
Caris Life Sciences and ECOG-ACRIN Partner to Interrogate Landmark TAILORx Breast Cancer Trial
The first project under a new multi-year research collaboration, interrogation of the TAILORx breast cancer trial enables discovery for risk...
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
CHATHAM, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...
BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)
Additional real-world studies show sustained HAE attack rate reduction after initiating ORLADEYO, regardless of C1-INH status, and patient preference for...
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
Publication shows that OGM can resolve translocation partners involving MYC in multiple myeloma (MM) more effectively than current methodsThe release...
Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)
– Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive (1L) and imatinib-resistant (2L/3L) GIST models...
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company...
Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium
– Interim data from ongoing trial of PRT3789 showed additional clinical activity at higher doses in patients with non-small cell...
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
New clinical data from Phio's on-going Phase 1b trial to be presentedMarlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio...
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
New clinical data from Phio's on-going Phase 1b trial to be presentedMarlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio...
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
SPARKS, NV / ACCESSWIRE / October 24, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a leading USA-based biotechnology company, has...
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
SPARKS, NV / ACCESSWIRE / October 24, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a leading USA-based biotechnology company, has...
Final Day of Global Health Exhibition Celebrates the Next Generation of Health Innovators
Exhibition concludes with 105,000 attendees confirmed over three daysWinner of prestigious Vision NextGen startup competition revealed as X-Genome, an innovative biotech...
Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative
- The first tri-party executive roundtable was held in London to strengthen synergies for Seegene's vision of creating 'a world...
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance
Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving...